Patents by Inventor Kevin Draves

Kevin Draves has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Delivery of Antigens to Plasmacytoid Dendritic Cells
    Publication number: 20150238632
    Abstract: The present invention provides compositions of blood dendritic cell antigen 2 (BDCA2) targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.
    Type: Application
    Filed: September 18, 2013
    Publication date: August 27, 2015
    Inventors: Edward A. Clark, Craig Chappell, Natalia V. Giltiay, Kevin Draves
  • Dendritic cell-associated lectin-like molecules, compositions and methods of use
    Patent number: 8246959
    Abstract: The invention provides novel dendritic cell-associated lectin-like (DCAL-1) molecules, compositions and therapeutic methods of use. In one aspect, the invention provides isolated nucleic acid molecules that are capable of remaining hybridized to SEQ ID NO:1 or SEQ ID NO:3, including nucleic acid molecules that encode DCAL-1 polypeptides. In another aspect, the invention provides DCAL-1 polypeptides and portions thereof which are useful to stimulate T cell proliferation. In another aspect, the invention provides antibodies that specifically bind to DCAL-1 which are useful for promoting maturation of dendritic cells and for stimulating an immune response in vivo. In another aspect the invention provides methods of stimulating an immune response in an animal comprising introducing into the animal an anti-DCAL-1 antibody of the invention.
    Type: Grant
    Filed: January 5, 2007
    Date of Patent: August 21, 2012
    Assignee: University of Washington
    Inventors: Edward A. Clark, Elizabeth Ryan, Aaron Marshall, Kevin Draves